Insulin-Like Growth Factor I (IGF1) (30-41) (IGF-1 C-Peptide)
Cat# MBS635030-5mg
Size : 5mg
Brand : MyBiosource
Insulin-Like Growth Factor I (IGF1) Protein
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS635030C-Peptide is part of the molecule of Proinsulin, that consists of three parts: C-Peptide and two long strands of amino acids (called the alpha and beta chains) that later become linked together to form the insulin molecule. From every molecule of proinsulin,… More details
Product Overview
Online Datasheet in PDFProduct Name
Insulin-Like Growth Factor I (IGF1), Protein
Full Product Name
Insulin-Like Growth Factor I (IGF1) (30-41) (IGF-1 C-Peptide)
Product Gene Name
IGF1 protein
Host
Synthetic peptide
Form/Format
Supplied as a lyophilized powder.
Purity/Purification
Highly Purified
~95%. Purified by HPLC.
~95%. Purified by HPLC.
Preparation and Storage
Lyophilized powder may be stored at 4 degree C for short-term only. Stable for 12 months at -20 degree C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20 degree C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
Molecular Weight
21,841 Da
Chromosome Location
Chromosome: 12; NC_000012.11 (102789645..102875563, complement). Location: 12q23.2
OMIM
147440
Sequence (linear)
Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr
Product Categories/Family for IGF1 protein
Growth Factors; Cytokines; Growth Factors-IGF
Other Notes
Small volumes of IGF1 protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for IGF1 purchase
MBS635030 is a protein targeting IGF1. Also known as Insulin-Like Growth Factor I (IGF1) (30-41) (IGF-1 C-Peptide). Host: Synthetic peptide.
Additional Details
NCBI/Uniprot data below describe general gene information for IGF1. It may not necessarily be applicable to this product.
NCBI Official Full Name
insulin-like growth factor 1 isoform 4 preproprotein
NCBI Official Synonym Full Names
insulin-like growth factor 1 (somatomedin C)
NCBI Official Symbol
IGF1
NCBI Official Synonym Symbols
IGFI; IGF-I; IGF1A
UniProt Protein Name
Insulin-like growth factor I
UniProt Synonym Protein Names
Mechano growth factor; MGF; Somatomedin-C
Protein Family
Insulin-like growth factor
UniProt Gene Name
IGF1
UniProt Synonym Gene Names
IBP1; IGF-I; MGF
UniProt Entry Name
IGF1_HUMAN
NCBI Protein Information
insulin-like growth factor 1; MGF; IGF-IA; IGF-IB; somatomedin-C; mechano growth factor; insulin-like growth factor I; insulin-like growth factor IA; insulin-like growth factor IB
NCBI Summary for IGF1
The protein encoded by this gene is similar to insulin in function and structure and is a member of a family of proteins involved in mediating growth and development. The encoded protein is processed from a precursor, bound by a specific receptor, and secreted. Defects in this gene are a cause of insulin-like growth factor I deficiency. Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
Show more UniProt Comments for IGF1
IGF1: The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in rat bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. Defects in IGF1 are the cause of insulin-like growth factor I deficiency (IGF1 deficiency). IGF1 deficiency is an autosomal recessive disorder characterized by growth retardation, sensorineural deafness and mental retardation. Belongs to the insulin family. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Secreted, signal peptide; Motility/polarity/chemotaxis; Secreted
Chromosomal Location of Human Ortholog: 12q23.2
Cellular Component: insulin-like growth factor binding protein complex; extracellular space; extracellular region; plasma membrane
Molecular Function: integrin binding; insulin-like growth factor receptor binding; protein binding; growth factor activity; hormone activity; insulin receptor binding
Biological Process: muscle development; positive regulation of transcription, DNA-dependent; chondroitin sulfate proteoglycan biosynthetic process; glycolate metabolic process; exocrine pancreas development; water homeostasis; positive regulation of glucose import; positive regulation of fibroblast proliferation; proteoglycan biosynthetic process; inner ear development; positive regulation of DNA binding; muscle hypertrophy; platelet activation; positive regulation of protein import into nucleus, translocation; positive regulation of mitosis; regulation of establishment and/or maintenance of cell polarity; positive regulation of phosphoinositide 3-kinase cascade; cell activation; positive regulation of peptidyl-tyrosine phosphorylation; insulin-like growth factor receptor signaling pathway; branching morphogenesis of a tube; regulation of gene expression; response to heat; positive regulation of transcription from RNA polymerase II promoter; alveolus development; positive regulation of epithelial cell proliferation; negative regulation of apoptosis; positive regulation of insulin-like growth factor receptor signaling pathway; myoblast proliferation; positive regulation of smooth muscle cell proliferation; positive regulation of glycogen biosynthetic process; signal transduction; positive regulation of smooth muscle cell migration; positive regulation of activated T cell proliferation; negative regulation of cell proliferation; platelet degranulation; glial cell differentiation; mammary gland development; positive regulation of MAPKKK cascade; positive regulation of cell proliferation; DNA replication; skeletal development; positive regulation of granule cell precursor proliferation; phosphoinositide-mediated signaling; multicellular organism growth; regulation of multicellular organism growth; myotube cell development; satellite cell compartment self-renewal involved in skeletal muscle regeneration; myoblast differentiation; positive regulation of osteoblast differentiation; positive regulation of protein kinase B signaling cascade; cell proliferation; cellular protein metabolic process; positive regulation of tyrosine phosphorylation of Stat5 protein; Ras protein signal transduction; positive regulation of glycolysis; blood vessel remodeling; positive regulation of Ras protein signal transduction; blood coagulation; cell motility; positive regulation of DNA replication
Disease: Insulin-like Growth Factor I Deficiency
Show more Protein type: Secreted, signal peptide; Motility/polarity/chemotaxis; Secreted
Chromosomal Location of Human Ortholog: 12q23.2
Cellular Component: insulin-like growth factor binding protein complex; extracellular space; extracellular region; plasma membrane
Molecular Function: integrin binding; insulin-like growth factor receptor binding; protein binding; growth factor activity; hormone activity; insulin receptor binding
Biological Process: muscle development; positive regulation of transcription, DNA-dependent; chondroitin sulfate proteoglycan biosynthetic process; glycolate metabolic process; exocrine pancreas development; water homeostasis; positive regulation of glucose import; positive regulation of fibroblast proliferation; proteoglycan biosynthetic process; inner ear development; positive regulation of DNA binding; muscle hypertrophy; platelet activation; positive regulation of protein import into nucleus, translocation; positive regulation of mitosis; regulation of establishment and/or maintenance of cell polarity; positive regulation of phosphoinositide 3-kinase cascade; cell activation; positive regulation of peptidyl-tyrosine phosphorylation; insulin-like growth factor receptor signaling pathway; branching morphogenesis of a tube; regulation of gene expression; response to heat; positive regulation of transcription from RNA polymerase II promoter; alveolus development; positive regulation of epithelial cell proliferation; negative regulation of apoptosis; positive regulation of insulin-like growth factor receptor signaling pathway; myoblast proliferation; positive regulation of smooth muscle cell proliferation; positive regulation of glycogen biosynthetic process; signal transduction; positive regulation of smooth muscle cell migration; positive regulation of activated T cell proliferation; negative regulation of cell proliferation; platelet degranulation; glial cell differentiation; mammary gland development; positive regulation of MAPKKK cascade; positive regulation of cell proliferation; DNA replication; skeletal development; positive regulation of granule cell precursor proliferation; phosphoinositide-mediated signaling; multicellular organism growth; regulation of multicellular organism growth; myotube cell development; satellite cell compartment self-renewal involved in skeletal muscle regeneration; myoblast differentiation; positive regulation of osteoblast differentiation; positive regulation of protein kinase B signaling cascade; cell proliferation; cellular protein metabolic process; positive regulation of tyrosine phosphorylation of Stat5 protein; Ras protein signal transduction; positive regulation of glycolysis; blood vessel remodeling; positive regulation of Ras protein signal transduction; blood coagulation; cell motility; positive regulation of DNA replication
Disease: Insulin-like Growth Factor I Deficiency
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with IGF1 protein
| Reference Product | PubMed Publications |
|---|---|
| IGF1R protein | >340 publications with IGF1 and IGF1R |
| IGFBP3 protein | >182 publications with IGF1 and IGFBP3 |
| IGFBP1 protein | >64 publications with IGF1 and IGFBP1 |
| IRS1 protein | >60 publications with IGF1 and IRS1 |
| IGFBP2 protein | >46 publications with IGF1 and IGFBP2 |
| IRS2 protein | >34 publications with IGF1 and IRS2 |
| INSR protein | >26 publications with IGF1 and INSR |
| IGFBP5 protein | >26 publications with IGF1 and IGFBP5 |
| IGFBP4 protein | >20 publications with IGF1 and IGFBP4 |
| IGFBP6 protein | >7 publications with IGF1 and IGFBP6 |
Pathways associated with IGF1 protein
| Products by Pathway | Pathway Diagram |
|---|---|
| Adipogenesis Pathway antibodies | Adipogenesis Pathway Diagram |
| Aldosterone-regulated Sodium Reabsorption Pathway antibodies | Aldosterone-regulated Sodium Reabsorption Pathway Diagram |
| Aldosterone-regulated Sodium Reabsorption Pathway antibodies | Aldosterone-regulated Sodium Reabsorption Pathway Diagram |
| Apoptosis Pathway antibodies | Apoptosis Pathway Diagram |
| Cardiac Progenitor Differentiation Pathway antibodies | Cardiac Progenitor Differentiation Pathway Diagram |
| Dilated Cardiomyopathy Pathway antibodies | Dilated Cardiomyopathy Pathway Diagram |
| Dilated Cardiomyopathy Pathway antibodies | Dilated Cardiomyopathy Pathway Diagram |
| Endochondral Ossification Pathway antibodies | Endochondral Ossification Pathway Diagram |
| Focal Adhesion Pathway antibodies | Focal Adhesion Pathway Diagram |
| Focal Adhesion Pathway antibodies | Focal Adhesion Pathway Diagram |
Diseases associated with IGF1 protein
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >371 publications with IGF1 and Neoplasms |
| Insulin-Like Growth Factor I Deficiency Antibodies | >114 publications with IGF1 and Insulin-Like Growth Factor I Deficiency |
| Acromegaly Antibodies | >95 publications with IGF1 and Acromegaly |
| Breast Neoplasms Antibodies | >94 publications with IGF1 and Breast Neoplasms |
| Female Urogenital Diseases Antibodies | >73 publications with IGF1 and Female Urogenital Diseases |
| Inflammation Antibodies | >54 publications with IGF1 and Inflammation |
| Liver Diseases Antibodies | >50 publications with IGF1 and Liver Diseases |
| Adenoma Antibodies | >47 publications with IGF1 and Adenoma |
| Heart Diseases Antibodies | >42 publications with IGF1 and Heart Diseases |
| Prostatic Neoplasms Antibodies | >38 publications with IGF1 and Prostatic Neoplasms |
Organs/Tissues associated with IGF1 protein
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >478 publications with IGF1 and Blood |
| Muscle Antibodies | >226 publications with IGF1 and Muscle |
| Bone Antibodies | >201 publications with IGF1 and Bone |
| Liver Antibodies | >199 publications with IGF1 and Liver |
| Brain Antibodies | >158 publications with IGF1 and Brain |
| Ovary Antibodies | >94 publications with IGF1 and Ovary |
| Vascular Antibodies | >91 publications with IGF1 and Vascular |
| Connective Tissue Antibodies | >87 publications with IGF1 and Connective Tissue |
| Heart Antibodies | >85 publications with IGF1 and Heart |
| Kidney Antibodies | >66 publications with IGF1 and Kidney |


